Discover
AGIO
Agios Pharmaceuticals, Inc.
42.79
2 x 30.58
2 x 53.96
bid
ask
+
0.03
0.07%
2 @ 07:35 PM
43.17 +0.38 (0.89%)
| Ytd | 57.20% | |
| 1y | 9.52% |
41.98
day range
43.14
22.24
52 week range
62.58
| Open | 42.58 | Prev Close | 42.76 | Low | 41.98 | High | 43.14 | Mkt Cap | 2.62B |
| Vol | 497.91K | Avg Vol | 1.23M | EPS | -7.25 | P/E | N/A | Forward P/E | -9.33 |
| Beta | 0.54 | Short Ratio | 7.28 | Inst. Own | 109.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 30.77 | 200-d Avg | 31.80 | 1yr Est | 42.63 |
| Income Statement | |||
| Total Revenue | 20.75M | ||
| Revenues (USD) | 20.75M | ||
| Cost of Revenue | 1.32M | ||
| Gross Profit | 19.43M | ||
| Operating Expenses | 129.45M | ||
| Research and Development Expense | 81.15M | ||
| Selling, General and Administrative Expense | 48.30M | ||
| Operating Income | -110.02M | ||
| Net Income | -99.11M | ||
| Net Income Common Stock | -99.11M | ||
| Net Income Common Stock (USD) | -99.11M | ||
| Consolidated Income | -99.11M | ||
| Earnings per Basic Share | -1.69 | ||
| Earnings per Basic Share (USD) | -1.69 | ||
| Earnings per Diluted Share | -1.69 | ||
| Earning Before Interest & Taxes (EBIT) | -99.11M | ||
| Earning Before Interest & Taxes (USD) | -99.11M | ||
| Weighted Average Shares | 58.78M | ||
| Weighted Average Shares Diluted | 58.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 113.60M | ||
| Cash and Equivalents (USD) | 113.60M | ||
| Investments | 931.89M | ||
| Investments Current | 623.44M | ||
| Investments Non-Current | 308.45M | ||
| Trade and Non-Trade Receivables | 16.13M | ||
| Current Assets | 834.84M | ||
| Property, Plant & Equipment Net | 37.76M | ||
| Total Assets | 1.18B | ||
| Debt Current | 18.81M | ||
| Total Debt | 35.74M | ||
| Current Liabilities | 58.85M | ||
| Debt Non-Current | 16.94M | ||
| Total Liabilities | 75.88M | ||
| Accumulated Retained Earnings (Deficit) | -660.82M | ||
| Accumulated Other Comprehensive Income | -314.00K | ||
| Shareholders Equity | 1.11B | ||
| Shareholders Equity (USD) | 1.11B | ||
| Assets Non-Current | 350.15M | ||
| Total Debt (USD) | 35.74M | ||
| Inventory | 35.09M | ||
| Liabilities Non-Current | 17.03M | ||
| Trade and Non-Trade Payables | 13.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.62M | ||
| Net Cash Flow from Financing | 2.08M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 24.47M | ||
| Capital Expenditure | -769.00K | ||
| Issuance (Purchase) of Equity Shares | 2.08M | ||
| Net Cash Flow from Investing | 141.31M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 142.08M | ||
| Net Cash Flow from Operations | -118.92M | ||
| Share Based Compensation | 15.54M | ||